BPDCN is a rare blood cancer linked to plasmacytoid dendritic cells. It is discussed as a systemic disease because it can involve skin, blood, marrow, lymph nodes, and sometimes the central nervous system.
Use this page as the stable reference before reading research updates.
Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematologic cancer. Educational sources describe it as involving plasmacytoid dendritic cells and often discuss more than one body system.
Some BPDCN facts are stable, such as its rarity and common discussion around skin and marrow. Other areas, including optimal treatment sequencing and trial results, change as new studies appear.
BPDCN is a rare blood cancer linked to plasmacytoid dendritic cells. It is discussed as a systemic disease because it can involve skin, blood, marrow, lymph nodes, and sometimes the central nervous system.
Use this page as the stable reference before reading research updates.
Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematologic cancer. Educational sources describe it as involving plasmacytoid dendritic cells and often discuss more than one body system.
Some BPDCN facts are stable, such as its rarity and common discussion around skin and marrow. Other areas, including optimal treatment sequencing and trial results, change as new studies appear.
